High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation. A randomized controlled trial evaluating the relationship to endothelial function and inflammation

American Heart Journal

Volumn 158, Issue 5, 2009, Pages 734-741

  Munk, Peter S ^a,b   Staal, Eva M ^a,b   Butt, Noreen ^a   Isaksen, Kjetil ^a   Larsen, Alf I ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AEROBIC CAPACITY; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MALE; OXYGEN CONSUMPTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK REDUCTION; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; TRAINING; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EXERCISE; FEMALE; HEMANGIOENDOTHELIOMA; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; STENTS;

EID: 70350241393     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.08.021     Document Type: Article

References (33)

1. Taylor R.S., Brown A., Ebrahim S., et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004) 682-692
2. Piepoli M.F., Davos C., Francis D.P., et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328 (2004) 189
3. Suaya J.A., Shepard D.S., Normand S.L., et al. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 116 (2007) 1653-1662
4. Cannan C.R., Yeh W., Kelsey S.F., et al. Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol 84 (1999) 170-175
5. Post M.J., de Smet B.J., van der Helm Y., et al. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation 96 (1997) 996-1003
6. Wentzel J.J., Krams R., Schuurbiers J.C., et al. Relationship between neointimal thickness and shear stress after wall stent implantation in human coronary arteries. Circulation 103 (2001) 1740-1745
7. Saleh N., and Tornvall P. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis. Atherosclerosis 195 (2007) 374-378
8. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
9. Kastrati A., Mehilli J., Pache J., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
10. Balady G.J., Williams M.A., Ades P.A., et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 115 (2007) 2675-2682
11. Rognmo O., Hetland E., Helgerud J., et al. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 11 (2004) 216-222
12. Tjonna A.E., Lee S.J., Rognmo O., et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118 (2008) 346-354
13. Wisloff U., Stoylen A., Loennechen J.P., et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115 (2007) 3086-3094
14. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
15. Krone R.J., Laskey W.K., Johnson C., et al. A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention. Am J Cardiol 85 (2000) 1179-1184
16. Belardinelli R., Paolini I., Cianci G., et al. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 37 (2001) 1891-1900
17. Serruys P.W., Kutryk M.J., and Ong A.T. Coronary-artery stents. N Engl J Med 354 (2006) 483-495
18. Walter D.H., Schachinger V., Elsner M., et al. Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol 85 (2000) 962-968
19. Stone G.W., Midei M., Newman W., et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299 (2008) 1903-1913
20. Myers J., Prakash M., Froelicher V., et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 (2002) 793-801
21. Hambrecht R., Adams V., Erbs S., et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107 (2003) 3152-3158
22. Lipke E.A., and West J.L. Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. Acta Biomater 1 (2005) 597-606
23. Willerson J.T., and Kereiakes D.J. Endothelial dysfunction. Circulation 108 (2003) 2060-2061
24. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
25. Patti G., Pasceri V., Melfi R., et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 111 (2005) 70-75
26. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 (1995) 1235-1241
27. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49 (2007) 2129-2138
28. Ferrante G., Niccoli G., Biasucci L.M., et al. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med 9 (2008) 156-165
29. Goldhammer E., Tanchilevitch A., Maor I., et al. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 100 (2005) 93-99
30. Adamopoulos S., Parissis J., Kroupis C., et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22 (2001) 791-797
31. Venugopal S.K., Devaraj S., Yuhanna I., et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106 (2002) 1439-1441
32. Danenberg H.D., Szalai A.J., Swaminathan R.V., et al. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 108 (2003) 512-515
33. Xing D., Hage F.G., Chen Y.F., et al. Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. Am J Pathol 172 (2008) 22-30